Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).
Grassi, C
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). [electronic resource] - Journal of chemotherapy (Florence, Italy) Dec 2002 - 597-608 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1120-009X
10.1179/joc.2002.14.6.597 doi
Acute Disease
Aged
Anti-Infective Agents--administration & dosage
Aza Compounds
Bronchitis, Chronic--drug therapy
Ceftriaxone--administration & dosage
Costs and Cost Analysis
Female
Fluoroquinolones
Humans
Italy
Male
Middle Aged
Moxifloxacin
National Health Programs--economics
Quinolines
Time Factors
Treatment Outcome
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). [electronic resource] - Journal of chemotherapy (Florence, Italy) Dec 2002 - 597-608 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1120-009X
10.1179/joc.2002.14.6.597 doi
Acute Disease
Aged
Anti-Infective Agents--administration & dosage
Aza Compounds
Bronchitis, Chronic--drug therapy
Ceftriaxone--administration & dosage
Costs and Cost Analysis
Female
Fluoroquinolones
Humans
Italy
Male
Middle Aged
Moxifloxacin
National Health Programs--economics
Quinolines
Time Factors
Treatment Outcome